PhaseBio Pharmaceuticals Inc sell PlusUltra
Start price
12.12.20
/
50%
€3.60
Target price
12.12.21
-
Performance (%)
-42.22%
End price
13.12.21
€2.08
Summary
This prediction ended on 13.12.21 with a price of €2.08. The SELL prediction by PlusUltra for PhaseBio Pharmaceuticals Inc performed very well with a performance of -42.22%. PlusUltra has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| PhaseBio Pharmaceuticals Inc | - | - | - | - |
| iShares Core DAX® | -1.370% | -3.231% | 11.661% | 16.545% |
| iShares Nasdaq 100 | 0.172% | -3.339% | 36.491% | 43.334% |
| iShares Nikkei 225® | -0.801% | -7.859% | 18.597% | 4.253% |
| iShares S&P 500 | -0.369% | -2.979% | 26.341% | 40.911% |
According to PlusUltra what are the pros and cons of PhaseBio Pharmaceuticals Inc for the foreseeable future?
Pros
Cons
Probably not worthwhile Investment
Comments by PlusUltra for this prediction
In the thread Discuss PhaseBio Pharmaceuticals Inc
Sell PhaseBio Pharmaceuticals Inc
In the thread Trading PhaseBio Pharmaceuticals Inc
Die von PlusUltra gewählte maximale Laufzeit wurde überschritten